Table 1.
Deferoxamine | Deferasirox | Deferiprone | |
---|---|---|---|
Structure | |||
Administration route | Subcutaneousa | Oral | Oral |
Recommended dose for transfusional iron overload | 1000–2000 mg (20–40 mg/kg/day) | Deferasirox DT Starting dose: 20 mg/kg/day Maximum dose: 40 mg/kg/day Deferasirox FCT Starting dose: 14 mg/kg/day Maximum dose: 28 mg/kg/day |
25–33 mg/kg TID (75–99 mg/kg/day) |
Half-life | 18–20 minutes | 8–16 hoursb | 1.9 hours |
Approximate daily iron cleared | 0.05–0.19 mg Fe/kg body weight/day | 0.1–0.5 mg Fe/kg body weight/dayb | 0.03–0.4 mg/kg body weight/day |
Elimination | Primarily urine | Primarily fecalb | Primarily urine |
DT, dispersible tablet; FCT, film-coated tablet; TID, 3 times a day.
Recommended; may also be administered intravenously and intramuscularly.
Studies were performed using deferasirox DT for oral suspension.